The Cigna Group

NYSE:CI Stock Report

Market Cap: US$83.4b

Cigna Group Past Earnings Performance

Past criteria checks 0/6

Cigna Group's earnings have been declining at an average annual rate of -9%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 8.5% per year. Cigna Group's return on equity is 9.2%, and it has net margins of 1.4%.

Key information

-9.0%

Earnings growth rate

-3.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate8.5%
Return on equity9.2%
Net Margin1.4%
Last Earnings Update31 Dec 2024

Recent past performance updates

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

May 09
Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

Recent updates

Cigna Is A Buy: Market Overreaction Creates A Big Opportunity

Feb 17

Investors Will Want Cigna Group's (NYSE:CI) Growth In ROCE To Persist

Jan 31
Investors Will Want Cigna Group's (NYSE:CI) Growth In ROCE To Persist

Cigna: Buy The Drop On This Undervalued Growth Stock

Jan 18

The Cigna Group's (NYSE:CI) Earnings Haven't Escaped The Attention Of Investors

Dec 29
The Cigna Group's (NYSE:CI) Earnings Haven't Escaped The Attention Of Investors

Cigna And The Risk Of PBMs - I'm Staying Out Above $230/Share

Dec 13

These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well

Oct 14
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well

Cigna: This Dividend Grower Could Be Worth Buying Now

Sep 26

Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)

Sep 26
Returns On Capital Are Showing Encouraging Signs At Cigna Group (NYSE:CI)

Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'

Sep 19

The Price Is Right For The Cigna Group (NYSE:CI)

Sep 08
The Price Is Right For The Cigna Group (NYSE:CI)

Cigna Group: Services Focus Leads To Outperformance

Jul 29

Cigna: Game Over For PBMs?

Jul 12

Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet

Jun 14
Cigna Group (NYSE:CI) Has A Somewhat Strained Balance Sheet

Cigna: Will Benefit From Lower Medicaid Enrollments

Jun 11

The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing

May 27
The Cigna Group (NYSE:CI) Not Lagging Market On Growth Or Pricing

Cigna: An Up-And-Coming Dividend Growth Stock To Buy Now

May 13

Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

May 09
Cigna Group's (NYSE:CI) Soft Earnings Don't Show The Whole Picture

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Apr 18
Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Apr 09

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Apr 05
Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

Apr 01

Cigna: Trimming The Fat And Staying Focused

Mar 05

Cigna: Big Buybacks And Total Return Potential

Feb 26

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

Jan 29

Why Dividend Growth Investors Should Buy Cigna

Jan 18

Cigna: Sentiment And Fundamentals On Their Side

Dec 21

Cigna's Merger Fumble: A Festive Financial Rebound

Dec 11

Humana And Cigna Topple On Rumors Of An Unlikely Union

Nov 30

Cigna Delivering Growth At A Great Price

Nov 13

Cigna: Too Cheap To Ignore

Oct 24

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Oct 01

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Sep 14

Cigna Group: Weaker Than Peers But Still A Buy

Aug 27

Cigna: Buy During The Next Correction (Technical Analysis)

Aug 08

Revenue & Expenses Breakdown

How Cigna Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:CI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24247,1213,43414,5690
30 Sep 24232,5863,03914,6220
30 Jun 24217,9403,70814,6850
31 Mar 24206,0033,62014,4960
31 Dec 23195,2655,16414,3700
30 Sep 23189,9045,32814,0500
30 Jun 23186,1376,67713,6090
31 Mar 23183,0296,77413,4210
31 Dec 22180,5186,70413,1100
30 Sep 22180,4536,62713,0420
30 Jun 22179,4605,49112,9990
31 Mar 22177,1135,40112,7480
31 Dec 21174,0695,37012,7910
30 Sep 21170,1028,38413,1950
30 Jun 21166,7698,15113,4020
31 Mar 21162,9038,43813,6970
31 Dec 20160,4018,45813,6600
30 Sep 20156,9345,30013,4840
30 Jun 20154,5355,26313,5210
31 Mar 20154,0894,91713,3860
31 Dec 19153,5665,10413,3150
30 Sep 19129,6214,27112,4790
30 Jun 19102,5223,69212,1960
31 Mar 1975,1833,09011,7390
31 Dec 1848,6502,63711,2300
30 Sep 1844,7682,75918,4050
30 Jun 1843,8002,54715,3430
31 Mar 1842,7452,55412,6400
31 Dec 1741,8062,2379,8460
30 Sep 1741,3322,353820
30 Jun 1740,7232,249820
31 Mar 1740,2581,946820
31 Dec 1639,8381,8679,6260
30 Sep 1639,2521,911920
30 Jun 1638,7612,002920
31 Mar 1638,2932,080920
31 Dec 1537,8762,094920
30 Sep 1537,2762,13500
30 Jun 1536,6442,12200
31 Mar 1535,8852,10700
31 Dec 1434,9142,102850
30 Sep 1434,1371,99600
30 Jun 1433,4462,01500
31 Mar 1432,6931,94700

Quality Earnings: CI has a large one-off loss of $3.0B impacting its last 12 months of financial results to 31st December, 2024.

Growing Profit Margin: CI's current net profit margins (1.4%) are lower than last year (2.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CI's earnings have declined by 9% per year over the past 5 years.

Accelerating Growth: CI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CI had negative earnings growth (-33.5%) over the past year, making it difficult to compare to the Healthcare industry average (20%).

Return on Equity

High ROE: CI's Return on Equity (9.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 22:38
End of Day Share Price 2025/02/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Cigna Group is covered by 44 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Hua HaBaird
Ishan MajumdarBaptista Research